日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Small molecule APOL1 inhibitors as a precision medicine approach for APOL1-mediated kidney disease

小分子APOL1抑制剂作为APOL1介导的肾脏疾病的精准治疗手段

Brandon Zimmerman # ,Leslie A Dakin # ,Anne Fortier ,Evanthia Nanou ,Angelo Blasio ,James Mann ,Howard Miller ,Marissa Fletcher ,Tiansheng Wang ,Suganthini Nanthakumar ,Gizelle McCarthy ,Caline Matar ,Prachi Matsye ,Guanyu Wang ,Phillip Snyder ,Kevin Daniel ,Harsha Swamy ,Kelly Sullivan ,Franklin Bright ,Audrey Powers ,Kevin J Gagnon ,Fan Lu ,Steven Paula ,Suvarna Khare-Pandit ,Larry Henry ,Martine Hamel ,Francois Denis ,Olivier Nicolas ,Niresh Hariparsad ,Shyamesh Kumar ,Jennifer Proctor ,Timothy Senter ,Brinley Furey ,Mark E Bunnage

Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control

利用构象控制进行结构引导设计强效且选择性的胞外信号调节激酶 (ERK) 嘧啶吡咯抑制剂

Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, Guy W Bemis, Jingrong Cao, Guanjing Chen, Nigel P Ewing, Pamella J Ford, Ursula A Germann, Jeremy Green, Michael R Hale, Marc Jacobs, James W Janetka, Francois Maltais, William Markland, Mark N Namchuk, Suganthini Nanthakumar, Srinivasu Poondru, Ju